Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Participants With Mild and Moderate Hepatic Impairment Compared to Healthy Participants
Clinical trial NCT04271488 · RECRUITING
Trial details
- NCT number
- NCT04271488
- Sponsor
- Eisai Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-27
- Primary completion
- 2026-11-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.